Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorEvren, Asaf E.
dc.contributor.authorNuha, Demokrat
dc.contributor.authorOzkan, Begum N. S.
dc.contributor.authorKahraman, Cigdem
dc.contributor.authorGonulalan, Ekrem M.
dc.contributor.authorYurttas, Leyla
dc.date.accessioned2025-12-28T16:38:53Z
dc.date.available2025-12-28T16:38:53Z
dc.date.issued2024
dc.identifier.issn0365-6233
dc.identifier.issn1521-4184
dc.identifier.urihttps://doi.org/10.1002/ardp.202400115
dc.identifier.urihttps://hdl.handle.net/20.500.12933/2143
dc.description.abstractThis study examines the synthesis and evaluation of 11 newly developed compounds as potential anti-Alzheimer's agents that occur via cholinesterase and beta-secretase inhibition. The compounds were tested for their inhibitory activity against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) using the modified Ellman method. The results showed that several compounds exhibited significant inhibition of AChE, particularly compounds 6d, 7a, and 7e, which demonstrated high inhibitory activity at lower concentrations, with IC50 values of 0.120, 0.039, and 0.063 mu M, respectively. However, the compounds showed limited effectiveness against BChE, with only a few compounds exhibiting moderate inhibition. Compound 7e showed an inhibitory effect against BACE-1 close to that of the standard drug. Structural analysis revealed that the compounds with substituted benzothiazole and thiazole moieties exhibited the most promising inhibitory activity. This study provides valuable insights into the potential of these synthesized derivatives as a treatment against Alzheimer's disease. Moreover, the structure, stability, and properties of the active compounds were further investigated using density functional theory calculations. As a final note, the utilization of molecular docking and molecular dynamics simulation studies allowed us to elucidate the action mechanism of the active compounds and gain insights into the structure-activity relationship against AChE and beta-secretase proteins. These computational techniques provide valuable information on the binding modes, interactions with target enzymes, dynamic behavior, and conformational changes of the compounds, enabling a comprehensive understanding of their biological activity. Analyzing the molecular interactions between compound 7e and the beta-secretase enzyme, the best docking pose within the enzyme's active pocket was identified. Molecular dynamics simulations were conducted for the 7a-acetylcholinesterase enzyme complex. Compounds with substituted benzothiazole and thiazole moieties exhibited the most promising inhibitory activity. image
dc.description.sponsorshipNone Funding Source: Medline
dc.language.isoen
dc.publisherWiley-V C H Verlag Gmbh
dc.relation.ispartofArchiv Der Pharmazie
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subject1,3,4-Oxadiazole
dc.subjectbeta-secretase
dc.subjectcholinesterase
dc.subjectmolecular docking
dc.subjectmolecular dynamics stimulation
dc.titleDesign and synthesis of phenoxy methyl-oxadiazole compounds against Alzheimer's disease
dc.typeArticle
dc.identifier.orcid0000-0002-7271-6791
dc.identifier.orcid0000-0002-8171-3824
dc.identifier.orcid0000-0002-8651-826X
dc.departmentAfyonkarahisar Sağlık Bilimleri Üniversitesi
dc.identifier.doi10.1002/ardp.202400115
dc.identifier.volume357
dc.identifier.issue8
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.department-temp[Evren, Asaf E.; Nuha, Demokrat; Ozkan, Begum N. S.; Yurttas, Leyla] Anadolu Univ, Fac Pharm, Dept Pharmaceut Chem, Eskisehir, Turkiye; [Evren, Asaf E.] Bilecik Seyh Edebali Univ, Vocat Sch Hlth Serv, Dept Pharm Serv, Bilecik, Turkiye; [Nuha, Demokrat] Univ Business & Technol, Fac Pharm, Prishtina, Kosovo; [Kahraman, Cigdem] Hacettepe Univ, Fac Pharm, Dept Pharmacognosy, Ankara, Turkiye; [Gonulalan, Ekrem M.] Afyonkarahisar Saglik Bilimleri Univ, Fac Pharm, Dept Pharmacognosy, Afyon, Turkiye
dc.identifier.pmid38657203
dc.identifier.scopus2-s2.0-85191352029
dc.identifier.scopusqualityQ1
dc.identifier.wosWOS:001207395200001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.snmzKA_WoS_20251227


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster